Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)
Background: Bictegravir (BIC), a recently introduced integrase inhibitor, is available in a single tablet regimen with tenofovir alafenamide (TAF) and emtricitabine (FTC) (BIC-STR). This study aimed to describe a real-life experience with BIC-STR. Methods: We retrospectively analyzed the data of peo...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2023-12-01
|
| Col·lecció: | Infectious Disease Reports |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2036-7449/15/6/69 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|